Pathogenetic Therapy of Epidermolysis Bullosa: Current State and Prospects.
Sign Up to like & getrecommendations! Published in 2021 at "Bulletin of experimental biology and medicine"
DOI: 10.1007/s10517-021-05182-8
Abstract: Epidermolysis bullosa is a severe hereditary disease caused by mutations in genes encoding cutaneous basement membrane proteins. These mutations lead to dermal-epidermal junction failure and, as a result, to disturbances in the morphological integrity of… read more here.
Keywords: pathogenetic therapy; epidermolysis bullosa; epidermolysis; therapy epidermolysis ... See more keywords
Serotoninergic system targeting in multiple sclerosis: the prospective for pathogenetic therapy.
Sign Up to like & getrecommendations! Published in 2021 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2021.102888
Abstract: Serotonin (5-hydroxytryptamine) (5-HT) is a neurotransmitter, which mediates neuropsychological functions of the central nervous system (CNS). Recent studies have shown the modulatory effect of 5-HT on gut microbiota functions, which play an essential role in… read more here.
Keywords: serotoninergic system; sclerosis; multiple sclerosis; pathogenetic therapy ... See more keywords